Nolan Sean P. 4
4 · Taysha Gene Therapies, Inc. · Filed Aug 16, 2023
Insider Transaction Report
Form 4
Nolan Sean P.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-08-16$0.90/sh+444,444$400,000→ 1,535,545 total(indirect: See Footnote)
Holdings
- 1,170
Common Stock
Footnotes (1)
- [F1]The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC.